Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8770301 | Journal of Renal Nutrition | 2018 | 10 Pages |
Abstract
On the other side, sodium and potassium play an important role in the control of arterial blood pressure and are involved in the development and progression of chronic kidney disease. Reduction of sodium intake and increase of potassium intake determine a decrease of arterial blood pressure with a beneficial effect on the kidney; however, adherence to sodium restriction is very poor. Regarding this, sodium-hydrogen exchanger isoform 3 inhibitors may reduce sodium absorption in the gut. The most recent sodium-hydrogen exchanger isoform 3 inhibitor, known as tenapanor, reduces extracellular fluid volume, left ventricular hypertrophy, albuminuria, and blood pressure in experimental studies and increases fecal loss of sodium in humans.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Luca MD, Valeria MD, Sebastiano MD, Antonio MD, Francesca MD, Carlo Alberto MD, Viviana MD, Domenico MD, Michele MD,